Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation for Breast Cancer Radiodermatitis Prevention. A Randomized Controlled Trial.

NCT04059809 is registered in ClinicalTrials.gov with AC Camargo Cancer Center as lead sponsor.

NCT NCT04059809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04059809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation for Breast Cancer Radiodermatitis Prevention. A Randomized Controlled Trial.
Lead sponsor
AC Camargo Cancer Center
Phase
Phase 2/3
Overall status
Completed
Start date
September 26, 2018
Completion date
July 20, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, quality of life, radiation dermatitis, radiation injuries, radiation toxicity, radiodermatitis, radiotherapy side effect